There is much merit to the business model of expanding clinics and tissue sampling revenues, increasing license fees and maybe entering cryo storage markets..
A minor cash infusion coupled with a RM or acquisition could rapidly increase revenues. Rumors on here of Guatemala , Chaum, Intellihealth in Thailand, other US locations all licensing at some point. Expansion is critical for proliferation. Acquisition may be a quick way to expand. Bring in Dinosaur to help structure partnerships or M&A to expand revenues..
Increasing revs in the stem cell space will bring investors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.